Geisinger, Merck collaborate for patient adherence
Geisinger Health System and pharmaceutical company Merck will enter into a new multi-year collaboration designed to improve patient health outcomes by focusing on shared decision making between patients and physicians and improved patient adherence.
Teams from Danville, Pa.-based Geisinger and Whitehouse Station, N.J.-based Merck will work together to improve patient adherence, increase the role of patients in making decisions to help manage their conditions, share information among extended care teams and improve clinical care processes, according to a statement from the organizations.
The first tool being developed is an interactive web application designed to help primary care clinicians assess and engage patients at risk for cardiometabolic syndrome, a clustering of various risk factors that puts an individual at risk of developing type 2 diabetes and cardiovascular disease.
The web application and other care management tools Merck and Geisinger develop will initially be tested within the Geisinger system, they added.
Teams from Danville, Pa.-based Geisinger and Whitehouse Station, N.J.-based Merck will work together to improve patient adherence, increase the role of patients in making decisions to help manage their conditions, share information among extended care teams and improve clinical care processes, according to a statement from the organizations.
The first tool being developed is an interactive web application designed to help primary care clinicians assess and engage patients at risk for cardiometabolic syndrome, a clustering of various risk factors that puts an individual at risk of developing type 2 diabetes and cardiovascular disease.
The web application and other care management tools Merck and Geisinger develop will initially be tested within the Geisinger system, they added.